1. Home
  2. PCVX vs KBH Comparison

PCVX vs KBH Comparison

Compare PCVX & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • KBH
  • Stock Information
  • Founded
  • PCVX 2013
  • KBH 1957
  • Country
  • PCVX United States
  • KBH United States
  • Employees
  • PCVX N/A
  • KBH N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • KBH Homebuilding
  • Sector
  • PCVX Health Care
  • KBH Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • KBH Nasdaq
  • Market Cap
  • PCVX 4.5B
  • KBH 3.9B
  • IPO Year
  • PCVX 2020
  • KBH 1987
  • Fundamental
  • Price
  • PCVX $31.16
  • KBH $53.96
  • Analyst Decision
  • PCVX Strong Buy
  • KBH Hold
  • Analyst Count
  • PCVX 10
  • KBH 13
  • Target Price
  • PCVX $136.50
  • KBH $71.65
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • KBH 1.3M
  • Earning Date
  • PCVX 05-07-2025
  • KBH 06-17-2025
  • Dividend Yield
  • PCVX N/A
  • KBH 1.85%
  • EPS Growth
  • PCVX N/A
  • KBH 11.73
  • EPS
  • PCVX N/A
  • KBH 8.22
  • Revenue
  • PCVX N/A
  • KBH $6,854,097,000.00
  • Revenue This Year
  • PCVX N/A
  • KBH N/A
  • Revenue Next Year
  • PCVX N/A
  • KBH N/A
  • P/E Ratio
  • PCVX N/A
  • KBH $6.59
  • Revenue Growth
  • PCVX N/A
  • KBH 5.54
  • 52 Week Low
  • PCVX $27.66
  • KBH $48.90
  • 52 Week High
  • PCVX $121.06
  • KBH $89.70
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • KBH 47.51
  • Support Level
  • PCVX $28.09
  • KBH $52.86
  • Resistance Level
  • PCVX $33.75
  • KBH $55.10
  • Average True Range (ATR)
  • PCVX 2.54
  • KBH 1.44
  • MACD
  • PCVX 1.12
  • KBH 0.39
  • Stochastic Oscillator
  • PCVX 35.61
  • KBH 51.41

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

Share on Social Networks: